International Journal of Cancer A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from PNOC


This clinical trial evaluated whether whole exome sequencing (WES) and RNA sequencing (RNAseq) of paired normal and tumor tissues could be incorporated into a personalized treatment plan for newly diagnosed patients (<25 years of age) with diffuse intrinsic pontine glioma (DIPG).


Previous
Previous

Journal of Neurosurgery Liquid biopsy for diffuse intrinsic pontine glioma: an update

Next
Next

DIPG-76 PNOC-003: trial for children with diffuse intrinsic pontine glioma: preliminary experience with multi-agent personalized therapy recommendations